About Hypogen

About company

Hypogen, Inc., is a biopharmaceutical company focused on the development of novel diagnostic tests and new therapeutics for essential hypertension. Hypertension is the world’s most prevalent disease, affecting more than 25 percent of the population, and continues to be a leading cause of morbidity and mortality. The National Heart, Lung, and Blood Institute reports that more than 30 percent of Americans with hypertension are unaware that they have high blood pressure, and less than 25 percent of those with hypertension actually have their condition controlled by prescription medications. As a result, it is estimated that more that 50 million people in the United States alone stand to benefit from improved diagnostic methods and more effective therapies. Hypogen’s mission is to meet this need.